Our vision:
Be the leader in bone-targeted drug delivery to cure bone cancer and metastases

Atlanthera has been developing a robust pipeline and is generating product candidates designed to provide durable efficacy .

Our focus on the rare diseases and on the patient is supported by preclinical and clinical development expertise and internal capabilities in compound optimization, chemical synthesis and in-vitro and in-vivo assay development.

Our Key figures:

 

You would like to become a financial partner of Atlanthera Company? Please feel free to contact us >